![Teresa Marie Bitetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Teresa Marie Bitetti
President chez
ARIAD PHARMACEUTICALS, INC.
Fortune : 5 M $ au 30/06/2026
Profil
Teresa Marie Bitetti is currently President & Director at ARIAD Pharmaceuticals, Inc., President & Director at Millennium Pharmaceuticals, Inc., Independent Director at Osmol Therapeutics, Inc., Independent Director at Aura Biosciences, Inc. starting in 2025, and President-Global Oncology Business Unit at Takeda Pharmaceutical Co., Ltd. since 2019.
Former roles include Director at Fusion Pharmaceuticals, Inc. from 2023 to 2024, Trustee at Cancer Care, Inc., SVP & Head-Worldwide Oncology Commercialization at Bristol Myers Squibb Co. from 2017 to 2019, and President & General Manager at The Bristol-Myers Squibb Canada Co. from 2010 to 2013.
Education includes undergraduate studies at Wellesley College and an MBA from the University of Virginia Darden School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 151 011 ( 0,01% ) | 5 M $ | 30/06/2026 | |
AURA BIOSCIENCES INC 0,06% | 11/06/2026 | 36 000 ( 0,06% ) | 255 600 $ | 30/06/2026 |
Postes actifs de Teresa Marie Bitetti
| Sociétés | Poste | Début |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | President | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/04/2019 |
| AURA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 31/03/2025 |
Osmol Therapeutics, Inc.
 Osmol Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for the treatment of chemotherapy | Directeur/Membre du Conseil | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | President | - |
Anciens postes connus de Teresa Marie Bitetti
| Sociétés | Poste | Fin |
|---|---|---|
| FUSN PHAR | Directeur/Membre du Conseil | 04/06/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 10/01/2019 |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | President | 01/01/2013 |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Directeur/Membre du Conseil | - |
Formation de Teresa Marie Bitetti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Care, Inc.
Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osmol Therapeutics, Inc.
Osmol Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for the treatment of chemotherapy | Commercial Services |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Choisissez Zonebourse 
